about
Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial datasetUse of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator).Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes.Evaluation of factors affecting CGMS calibration.Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin.Continuous glucose monitoring in children with type 1 diabetesDesign and baseline data from a PCORI-funded randomized controlled trial of family-centered tailoring of diabetes self-management resources.Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children.FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group.Recent advances in insulin treatment of children.The effect of continuous glucose monitoring in well-controlled type 1 diabetesBlunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes.Continuous glucose monitoring in youth with type 1 diabetes.Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin.Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.Continuous glucose monitoring and intensive treatment of type 1 diabetes.Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes.Redefining the clinical remission period in children with type 1 diabetes.The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control.Use of insulin glargine in children under age 6 with type 1 diabetes.
P50
Q30498210-DC228DB1-748B-4878-8B08-78A21F506213Q31144145-7A87096F-C207-4CB3-BD6C-E7163DE1F8E9Q34213303-34F08A42-5CDB-4B70-8133-34EE40A73ACFQ34700508-B54A7C0E-618C-4CE6-8B0A-F8CF4FA305F1Q35060269-39C2BF0B-12BF-4456-97CF-EB92782BEC78Q36098103-919F34FD-C87D-4A28-8B0E-DEEB18553037Q36356995-6FCEA07F-2420-46B6-B87F-A9E853AAD10DQ36478852-BFCF113B-D32A-4EB9-8C03-578931C47AA8Q36549174-652CAFD0-1CDF-497A-BF14-D011B50429F2Q36627309-65919039-7D89-4A8E-B1DA-D76AA1D32990Q36922326-78ED1A76-DFF0-44BB-839D-439215593172Q37269538-AAFF11DA-F45B-4A35-81DF-350F903301BFQ37400838-930B765E-DB2E-439B-9340-D8A5ABD9A096Q39962379-627FCD89-F38B-4921-A033-2102611FD45AQ44681492-6B7623A1-C1E1-48E9-9228-DFBFD99416A9Q46142750-784B1607-1F42-4914-99AE-8C2788E91BFDQ46380752-983D2865-1A44-4B42-BFEB-B7528C34E8AEQ46398442-28E51152-D224-4F77-A7F7-1C4DE6FCA093Q47885436-6ABF6784-C20D-45F5-8B1B-B28FEF0A89F8Q51216319-D4EF04D4-E182-47AC-9928-05D0F4944580Q53284660-EA514D35-995C-48D4-B922-08645ABB378C
P50
name
Rosanna Fiallo-Scharer
@ast
Rosanna Fiallo-Scharer
@en
Rosanna Fiallo-Scharer
@nl
type
label
Rosanna Fiallo-Scharer
@ast
Rosanna Fiallo-Scharer
@en
Rosanna Fiallo-Scharer
@nl
prefLabel
Rosanna Fiallo-Scharer
@ast
Rosanna Fiallo-Scharer
@en
Rosanna Fiallo-Scharer
@nl